Olga Vera

455 total citations
19 papers, 280 citations indexed

About

Olga Vera is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Olga Vera has authored 19 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Olga Vera's work include Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (8 papers) and Epigenetics and DNA Methylation (5 papers). Olga Vera is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (8 papers) and Epigenetics and DNA Methylation (5 papers). Olga Vera collaborates with scholars based in Spain, United States and Italy. Olga Vera's co-authors include Inmaculada Ibañez de Cáceres, Florian A. Karreth, Javier de Castro, Carlos Rodríguez‐Antolín, Olga Pernía, Javier Soto, Gina M. DeNicola, Thomas A. Sellers, Kaizhen Wang and Ana Dopazo and has published in prestigious journals such as Cancer Research, Oncogene and International Journal of Molecular Sciences.

In The Last Decade

Olga Vera

18 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olga Vera Spain 10 209 146 46 19 11 19 280
Jinze Shen China 10 220 1.1× 179 1.2× 34 0.7× 35 1.8× 17 1.5× 26 274
Guihong Zhang China 8 268 1.3× 238 1.6× 30 0.7× 39 2.1× 18 1.6× 13 347
Feilun Cui China 9 172 0.8× 88 0.6× 70 1.5× 35 1.8× 6 0.5× 29 250
Yufeng Li China 9 208 1.0× 112 0.8× 27 0.6× 54 2.8× 14 1.3× 24 284
Juliet Chijioke United States 4 282 1.3× 267 1.8× 40 0.9× 14 0.7× 14 1.3× 5 351
Belinda J. Petri United States 8 207 1.0× 162 1.1× 20 0.4× 27 1.4× 13 1.2× 13 257
Nabeel Attarwala United States 7 117 0.6× 69 0.5× 21 0.5× 21 1.1× 12 1.1× 12 168
Qian Dong China 7 217 1.0× 221 1.5× 44 1.0× 31 1.6× 14 1.3× 14 291
Timothy D. Klasson Netherlands 5 134 0.6× 66 0.5× 59 1.3× 16 0.8× 8 0.7× 6 196

Countries citing papers authored by Olga Vera

Since Specialization
Citations

This map shows the geographic impact of Olga Vera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Vera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Vera more than expected).

Fields of papers citing papers by Olga Vera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Vera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Vera. The network helps show where Olga Vera may publish in the future.

Co-authorship network of co-authors of Olga Vera

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Vera. A scholar is included among the top collaborators of Olga Vera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Vera. Olga Vera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Xu, Xiaonan, Yumi Kim, Kaizhen Wang, et al.. (2024). PHGDH Induction by MAPK Is Essential for Melanoma Formation and Creates an Actionable Metabolic Vulnerability. Cancer Research. 85(2). 314–328. 4 indexed citations
2.
Pernía, Olga, Oliver Higuera, Carlos Rodríguez‐Antolín, et al.. (2023). miR-124 as a Liquid Biopsy Prognostic Biomarker in Small Extracellular Vesicles from NSCLC Patients. International Journal of Molecular Sciences. 24(14). 11464–11464. 8 indexed citations
3.
Vera, Olga, et al.. (2023). Abstract 3739: MAFG promotes melanomagenesis through the transcriptional regulation of hypoxic and immune responses. Cancer Research. 83(7_Supplement). 3739–3739.
4.
Xu, Xiaonan, Kaizhen Wang, Olga Vera, et al.. (2022). Gain of Chromosome 1q Perturbs a Competitive Endogenous RNA Network to Promote Melanoma Metastasis. Cancer Research. 82(17). 3016–3031. 7 indexed citations
5.
Nenci, Arianna, et al.. (2022). Genetic tools for the stable overexpression of circular RNAs. RNA Biology. 19(1). 353–363. 22 indexed citations
6.
Vera, Olga, Koji Nakamura, Xiaonan Xu, et al.. (2021). A MAPK/miR-29 Axis Suppresses Melanoma by Targeting MAFG and MYBL2. Cancers. 13(6). 1408–1408. 22 indexed citations
7.
Vera, Olga, et al.. (2021). Squaring the circle: circRNAs in melanoma. Oncogene. 40(37). 5559–5566. 12 indexed citations
8.
Soto, Javier, Carlos Rodríguez‐Antolín, Olga Vera, et al.. (2021). Transcriptional epigenetic regulation of Fkbp1/Pax9 genes is associated with impaired sensitivity to platinum treatment in ovarian cancer. Clinical Epigenetics. 13(1). 167–167. 9 indexed citations
9.
Pernía, Olga, Ana Sastre-Perona, Carlos Rodríguez‐Antolín, et al.. (2020). A Novel Role for the Tumor Suppressor Gene ITF2 in Tumorigenesis and Chemotherapy Response. Cancers. 12(4). 786–786. 10 indexed citations
10.
Galera, Raúl, Raquel Casitas, Elisabet Martínez-Cerón, et al.. (2020). Hypermethylation of Anti-oncogenic MicroRNA 7 is Increased in Emphysema Patients. Archivos de Bronconeumología. 56(8). 506–513. 4 indexed citations
11.
Vera, Olga, et al.. (2020). Long Non-Coding RNAs in Melanoma Development and Biology. 14(2). 145–166. 1 indexed citations
12.
Vera, Olga, et al.. (2020). When Oxidative Stress Meets Epigenetics: Implications in Cancer Development. Antioxidants. 9(6). 468–468. 61 indexed citations
13.
Rodríguez‐Antolín, Carlos, Olga Pernía, Olga Vera, et al.. (2019). miR-7 methylation as a biomarker to predict poor survival in early-stage non-small cell lung cancer patients. Cell & Bioscience. 9(1). 63–63. 9 indexed citations
14.
Galera, Raúl, Raquel Casitas, Elisabet Martínez-Cerón, et al.. (2019). Hypermethylation of Anti-oncogenic MicroRNA 7 is Increased in Emphysema Patients. Archivos de Bronconeumología. 56(8). 506–513. 9 indexed citations
15.
Vera, Olga, Carlos Rodríguez‐Antolín, Patrycja Michalska, et al.. (2018). MAFG is a potential therapeutic target to restore chemosensitivity in cisplatin-resistant cancer cells by increasing reactive oxygen species. Translational research. 200. 1–17. 25 indexed citations
16.
Vera, Olga, Carlos Rodríguez‐Antolín, Javier de Castro, et al.. (2018). An epigenomic approach to identifying differential overlapping and cis-acting lncRNAs in cisplatin-resistant cancer cells. Epigenetics. 13(3). 251–263. 15 indexed citations
17.
Vera, Olga, Carlos Rodríguez‐Antolín, Olga Pernía, et al.. (2018). Abstract 4413: DNA methylation of miR-7 is a mechanism involved in platinum response through MAFG overexpression in cancer cells. Cancer Research. 78(13_Supplement). 4413–4413. 1 indexed citations
18.
Vera, Olga, Olga Pernía, Carlos Rodríguez‐Antolín, et al.. (2017). DNA Methylation of miR-7 is a Mechanism Involved in Platinum Response through MAFG Overexpression in Cancer Cells. Theranostics. 7(17). 4118–4134. 50 indexed citations
19.
Pernía, Olga, Cristóbal Belda-Iniesta, Verónica Pulido, et al.. (2014). Methylation status ofIGFBP-3as a useful clinical tool for deciding on a concomitant radiotherapy. Epigenetics. 9(11). 1446–1453. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026